CEO Kåre Engkilde presented at the annual Cell & Gene Meeting, which was held virtually April 6-9-2021
April 13, 2021
The Cell & Gene Meeting is organized by the Alliance for Regenerative Medicine. This year featuring more than 90 company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies. The meeting also included over 50 panelists and featured speakers taking part in 13 in-depth sessions covering all aspects of cell and gene therapy commercialization.